Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-003474

Options or other derivatives

  • Chief Operating Officer acquired 134,376 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stuart Bryan Chief Operating Officer 2021-01-25 Grant or award · Stock Option (right to buy) +134,376 134,376 D: show line 1 in the form
Loading xslF345X03/doc4.xml…